Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
Date:3/3/2010

uipment, net 1,124 2,514 Intangible assets, net 29,858 32,526 Goodwill 38,213 38,213 Other long-term assets 1,247 246 ----- --- Total assets $107,396 $117,498 ======== ======== LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Line of credit $9,399 $3,875 Accounts payable 2,158 5,736 Accrued liabilities 14,296 16,491 Senior secured notes 23,759 118,534 Purchased product rights liability 4,000 14,000 Liability under government settlement 2,954 2,533 Deferred revenue 2,675 12,322 ----- ------ Total current liabilities 59,241 173,491 Deferred rent 29 - Purchased product rights liability, noncurrent 9,000 - Deferred revenue, noncurrent 10,191 11,330 Liability under government settlement, noncurrent 10,658 13,063 Senior secured notes 91,107 - Common stock subject to repurchase - 12,492 Total stockholders' deficit (72,830) (92,878)
'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
7. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... YORK , Nov. 20, 2014  Market research firm ... the "Year of The Buy, in the medical device ... for medical devices will produce just 3% growth this ... actions, including acquisitions of product lines and entrance by ... annual survey of medical devices, The Global Market ...
(Date:11/21/2014)... SUNNYVALE, Calif. , Nov. 20, 2014 /PRNewswire/ ... Study at the 2014 AAGL Global Congress demonstrates ... vaginal insert designed to provide bowel control. One of ... MD, Associate Professor and Division Chief of Urogynecology ... North Carolina, won an Award for Best Written ...
(Date:11/21/2014)... BEVERLY HILLS, Calif. , Nov. 20, 2014 ... Ken Eaton , the election of Anthony J. ... as President. Effective November 19, 2014, ... and member of the Board of Directors of Oxis International, ... J. Cataldo has been named Chief Executive Officer of ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
(Date:11/21/2014)... Body Well Therapy, a leading provider of ... Spafinder massage gift cards and gift certificates for ... all service areas including throughout Florida and the DC Metro ... the spa at all to redeem your Spafinder massage gift ... "We may not be able to transport all of the ...
(Date:11/21/2014)... 2014 (HealthDay News) -- The cost of diabetes care ... recent years, climbing to more than $322 billion annually, ... cost were seen with prediabetes care, which have risen ... percent, the researchers added. In 2012, excess medical ... than $1,000 for every American. That total includes $244 ...
(Date:11/21/2014)... Nov. 21, 2014 (HealthDay News) -- Scientists say they,ve mapped ... extracted from a British man,s brain, in hopes it might ... Nov. 21 in the journal Genome Biology , the ... man of Chinese ethnicity. "This infection is so rare ... was not diagnosed ... until the worm was pulled out ...
(Date:11/21/2014)... MLF Biotech, Inc. has developed a ... for Pets helps maintain digestive health and can assist ... flora after it experiences a period of stress, dietary ... Pets is a proprietary blend of pure probiotics with ... bacteria strains that are safe and effective for both ...
(Date:11/21/2014)... November 21, 2014 Saint Luke’s ... With The Guidelines®–Heart Failure Gold-Plus Quality Achievement Award ... the American Heart Association/American College of Cardiology Foundation ... patients. , Get With The Guidelines–Heart Failure is ... provide the most up-to-date, research-based guidelines with the ...
Breaking Medicine News(10 mins):Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4
... June 24 Antibiotic resistance is one,of the ... and the focus of,today,s Senate hearing, Emergence of ... pose a threat to US healthcare,s reliance,on high ... for adversaries to exploit in building biological weapons., ...
... 24 The American Lung,Association commends and thanks ... the Pulmonary and Cardiac Rehabilitation Act today. As ... Providers Act of,2008, the Pulmonary and Cardiac Rehabilitation ... easier for millions of Americans who suffer from,serious ...
... Herrup and colleagues at Case Western Reserve University have ... brain cells effectively "puts the brakes" on the dementia ... fail, dementia results. , This discovery could open the ... affects up to half the population over the age ...
... leading provider of health and,human services for government ... the Iowa Department of Human Services (DHS) to ... in Iowa (hawk-i),Program. As part of Iowa,s State ... health insurance coverage for,uninsured children in Iowa whose ...
... Framework for Decision Making on ... State Retiree Health Care Benefits, WASHINGTON, June 24 ... Excellence looks at the complexities surrounding,the funding of state retiree ... Dollars and Health Sense: A Framework for Decision Making on,Funding ...
... "Heart disease,the main killer in the United States, ... largely treatable through diet, exercise and early,detection," an organization ... men and women die of cardiovascular disease each year ... can be elusive and patients may,have had no prior ...
Cached Medicine News:Health News:Federal Action Needed to Fill Antibiotic Pipeline, Says the Alliance for the Prudent Use of Antibiotics 2Health News:American Lung Association Commends U.S. House of Representatives for Passage of Pulmonary and Cardiac Rehabilitation Act 2Health News:Alzheimer's disease as a case of brake failure? 2Health News:Iowa Awards Policy Studies Inc. (PSI) Contract to Operate Its hawk-i Children's Health Insurance Program 2Health News:Balancing Dollars and Health Sense 2Health News:Concerns About Heart Disease Voiced 2
... The Anti-HCV Low Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... Comprehensive data from all major test systems ...
... The Anti-HCV Mixed Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by diagnostic manufacturers ... and RNA assays. Comprehensive data from all ...
... POPmesh is a ... that can be used ... pelvic floor procedures, including ... prolapse. Supple yet strong, ...
Suspend® Tutoplast® Processed Fascia Lata is your naturally safe and strong choice for pelvic floor reconstruction. Suspend comes from a dense matrix of collagen bundles and transverse fasc...
Medicine Products: